Merck said its experimental pill helped prevent serious illness and death in high-risk people infected with Covid-19, a step toward the virus’s first at-home treatment
Merck & Co. and its partner Ridgeback Biotherapeutics LP said their experimental Covid-19 pill helped prevent high-risk people early in the course of the disease in a pivotal study from becoming seriously ill and dying, a big step toward providing the pandemic’s first easy-to-use, at-home treatment.
The pill cut the risk of hospitalization or death in study subjects with mild to moderate Covid-19 by about 50%, the companies said Friday.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
School Boards Ask for Federal Help as Tensions Rise Over Covid-19 PoliciesAn organization representing school boards across the U.S. is asking the federal government for help in response to threats and harassment over Covid-19 protocols in schools
Baca lebih lajut »
How Monoclonal Antibody Therapies Fight Covid-19Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. Here's how the therapies work and why they’re important for saving lives.
Baca lebih lajut »
Parenting, Baby Names, Celebrities, and Royal News | CafeMom.com
Baca lebih lajut »